CLINICAL_TRIALS
trial_result
· 2025-03-17
Clinical Trial Update: A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure [Phase 1]
Summary
Phase 1 trial evaluating the safety of mRNA-0184 in participants with heart failure has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ModernaTX, Inc. | Conditions: Chronic Heart Failure | Phase 1 | Status: COMPLETED